[Pathophysiology, Diagnosis, and Therapy for the Management of Acquired Clotting Factor Deficiency]
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Weisdorf D, Hasegawa D, Fair D
. Acquired factor VII deficiency associated with aplastic anaemia: correction with bone marrow transplantation. Br J Haematol. 1989; 71(3):409-13.
DOI: 10.1111/j.1365-2141.1989.tb04299.x.
View
2.
Sun B, Xue F, Feng Y, Sun J, Yu Z, Hou M
. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China. Br J Haematol. 2019; 187(5):653-665.
DOI: 10.1111/bjh.16128.
View
3.
Menegatti M, Biguzzi E, Peyvandi F
. Management of rare acquired bleeding disorders. Hematology Am Soc Hematol Educ Program. 2019; 2019(1):80-87.
PMC: 6913473.
DOI: 10.1182/hematology.2019000066.
View
4.
Lavin M, Brophy T, Rawley O, OSullivan J, Hayden P, Browne P
. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. J Thromb Haemost. 2016; 14(6):1200-5.
DOI: 10.1111/jth.13317.
View
5.
Miller C
. Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay. Haemophilia. 2021; 27(5):823-829.
PMC: 8667261.
DOI: 10.1111/hae.14352.
View